WEKO3
アイテム
{"_buckets": {"deposit": "8228b79e-3cf8-497e-92dd-05f498505a6a"}, "_deposit": {"created_by": 1, "id": "67792", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "67792"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00067792", "sets": ["28"]}, "author_link": ["666116", "666117", "666115", "666113", "666112", "666114", "666111"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2004-05-28", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The effects of long-term administration of Zn-DTPA (diethyene-triamine-penta-actic acid) and CBMIDA [Catechol-3,6-bis(methyleiminodiaetic acid)] on plutonium-induced bone tumors and shortening of life span in rats were examined. One-hundred-twenty female rats were injected with doses of 18.5, 37, and 370 kBq/kg of plutonium-239. A daily intrperitoneally injected dose of 30 mmol/kg Ca-DTPA was administered to each of 40 rats of the 18.5, 37, and 370 kBq/kg of plutonium groups for first three days followed by the same dose of Zn-DTPA in orally administered in dinking water, while another 40 rats injected with 37 kBq/kg of plutonium were injected intraperitoneally with 30 mmol/kg CBMIDA for the first three days followed by oral administration. High urinary excretion of plutonium was observed for 14-21 days after plutonium injection in the chelating agent-treated groups. In the Zn-DTPA and CBMIDA treated groups, the mean life spans were significantly more prolonged compared with each corresponding (plutonium-injected) group. The incidences of bone tumors in the Zn-DTPA groups were reduced to zero from 10% in the 18.5 and 37 kBq/kg plutonium groups, while they increased to 10% from zero in the 370 kBq/kg plutonium group. The results indicated that human doses of Zn-DTPA and CBMIDA were effective in reducing plutonium-induced effects such as the shortening of life span and the induction of bone tumors in rats.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "11th International Congress of the International Radiation Protection Association", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Fukuda, Satoshi"}], "nameIdentifiers": [{"nameIdentifier": "666111", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Iida, Haruzo"}], "nameIdentifiers": [{"nameIdentifier": "666112", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yan, Xueming"}], "nameIdentifiers": [{"nameIdentifier": "666113", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Xie, Yuyuan"}], "nameIdentifiers": [{"nameIdentifier": "666114", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "福田 俊", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "666115", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "飯田 治三", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "666116", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "厳 雪銘", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "666117", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "A long-term treatment of chelating agents, Zn-DTPA and CBMIDA,reduces cancers and prevents shortening of life span in plutonium administered rats", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "A long-term treatment of chelating agents, Zn-DTPA and CBMIDA,reduces cancers and prevents shortening of life span in plutonium administered rats"}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/67792", "pubdate": {"attribute_name": "公開日", "attribute_value": "2004-05-31"}, "publish_date": "2004-05-31", "publish_status": "0", "recid": "67792", "relation": {}, "relation_version_is_last": true, "title": ["A long-term treatment of chelating agents, Zn-DTPA and CBMIDA,reduces cancers and prevents shortening of life span in plutonium administered rats"], "weko_shared_id": -1}
A long-term treatment of chelating agents, Zn-DTPA and CBMIDA,reduces cancers and prevents shortening of life span in plutonium administered rats
https://repo.qst.go.jp/records/67792
https://repo.qst.go.jp/records/677922d093b77-5c38-4f57-87e1-a7c78919d62f
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2004-05-31 | |||||
タイトル | ||||||
タイトル | A long-term treatment of chelating agents, Zn-DTPA and CBMIDA,reduces cancers and prevents shortening of life span in plutonium administered rats | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Fukuda, Satoshi
× Fukuda, Satoshi× Iida, Haruzo× Yan, Xueming× Xie, Yuyuan× 福田 俊× 飯田 治三× 厳 雪銘 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The effects of long-term administration of Zn-DTPA (diethyene-triamine-penta-actic acid) and CBMIDA [Catechol-3,6-bis(methyleiminodiaetic acid)] on plutonium-induced bone tumors and shortening of life span in rats were examined. One-hundred-twenty female rats were injected with doses of 18.5, 37, and 370 kBq/kg of plutonium-239. A daily intrperitoneally injected dose of 30 mmol/kg Ca-DTPA was administered to each of 40 rats of the 18.5, 37, and 370 kBq/kg of plutonium groups for first three days followed by the same dose of Zn-DTPA in orally administered in dinking water, while another 40 rats injected with 37 kBq/kg of plutonium were injected intraperitoneally with 30 mmol/kg CBMIDA for the first three days followed by oral administration. High urinary excretion of plutonium was observed for 14-21 days after plutonium injection in the chelating agent-treated groups. In the Zn-DTPA and CBMIDA treated groups, the mean life spans were significantly more prolonged compared with each corresponding (plutonium-injected) group. The incidences of bone tumors in the Zn-DTPA groups were reduced to zero from 10% in the 18.5 and 37 kBq/kg plutonium groups, while they increased to 10% from zero in the 370 kBq/kg plutonium group. The results indicated that human doses of Zn-DTPA and CBMIDA were effective in reducing plutonium-induced effects such as the shortening of life span and the induction of bone tumors in rats. | |||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 11th International Congress of the International Radiation Protection Association | |||||
発表年月日 | ||||||
日付 | 2004-05-28 | |||||
日付タイプ | Issued |